Loading…

Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults

One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, an...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1991-11, Vol.164 (5), p.973-975
Main Authors: Sha, Beverly E., Harris, Alan A., Benson, Constance A., Atkinson, William L., Urbanski, Pamela A., Stewart, John A., Williams, Walter W., Murphy, Robert L., Phair, John P., Levin, Stuart A., Kessler, Harold A.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13
cites
container_end_page 975
container_issue 5
container_start_page 973
container_title The Journal of infectious diseases
container_volume 164
creator Sha, Beverly E.
Harris, Alan A.
Benson, Constance A.
Atkinson, William L.
Urbanski, Pamela A.
Stewart, John A.
Williams, Walter W.
Murphy, Robert L.
Phair, John P.
Levin, Stuart A.
Kessler, Harold A.
description One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 ofimmunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient
doi_str_mv 10.1093/infdis/164.5.973
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72451691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30112014</jstor_id><sourcerecordid>30112014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13</originalsourceid><addsrcrecordid>eNpFkM1vEzEQxS0EKmnhzgVpD4jbpmN77V0fQwVNRBA9AEKVkOX4Q3LZ9aa2FzX_PY42hNNY-r33ZvwQeoNhiUHQax-c8eka82bJlqKlz9ACM9rWnGP6HC0ACKlxJ8RLdJnSAwA0lLcX6ALzjlDBFujXXbR_VG-DttXoqi9Wpd6mahWy343Gl6cP1Sodhn0eB5W9rtbToEK1GYYpjMY6r30xH6ofPk6p3gRndbamWpmpz-kVeuFUn-zr07xC3z99_Hazrrdfbzc3q22taUdzzQkRWmnDOgyEOcwdJzvijreyxsEODOCuo6C50KT80gihlHCYckUwVZheofdz7j6Oj5NNWQ4-adv3KthxSrIlDcNcHIUwC3UcU4rWyX30g4oHiUEeG5Vzo7I0Kpksu4rl7Sl72g3W_DfMFRb-7sRV0qp3UQVdAv7JGHB2DD7HPKQ8xjOmgDEB3BRez9ynbJ_OXMXfkre0ZXL9817e37YfPtMtyDv6F0sbmEM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72451691</pqid></control><display><type>article</type><title>Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults</title><source>JSTOR Archival Journals and Primary Sources Collection【Remote access available】</source><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Sha, Beverly E. ; Harris, Alan A. ; Benson, Constance A. ; Atkinson, William L. ; Urbanski, Pamela A. ; Stewart, John A. ; Williams, Walter W. ; Murphy, Robert L. ; Phair, John P. ; Levin, Stuart A. ; Kessler, Harold A.</creator><creatorcontrib>Sha, Beverly E. ; Harris, Alan A. ; Benson, Constance A. ; Atkinson, William L. ; Urbanski, Pamela A. ; Stewart, John A. ; Williams, Walter W. ; Murphy, Robert L. ; Phair, John P. ; Levin, Stuart A. ; Kessler, Harold A.</creatorcontrib><description>One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 ofimmunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient &lt;1%) lacked levels of antibody considered protective, Neither the presence nor the level of antibody were predictable from patient age, history of measles or immunization, CD4+ lymphocyte count, percentage of CD4+ cells, or CD4:CD8 ratio. Nearly all subjects had antibody to measles, regardless of immunization or measles history. Whether these antibodies are truly protective is unknown.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/164.5.973</identifier><identifier>PMID: 1682395</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Adult ; AIDS/HIV ; Antibodies ; Antibodies, Viral - blood ; Biological and medical sciences ; CD4-Positive T-Lymphocytes ; Chicago - epidemiology ; Children ; Concise Communications ; Disease Susceptibility ; Female ; HIV Infections - complications ; Humans ; Immunization ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Leukocyte Count ; Lymphocytes ; Male ; Measles ; Measles - complications ; Measles - epidemiology ; Measles - immunology ; Measles Vaccine - immunology ; Measles virus - immunology ; Medical sciences ; Middle Aged ; Notifiable diseases ; Patient medical history ; Percentages ; Prevalence ; Surveys and Questionnaires ; Vaccination ; Viruses</subject><ispartof>The Journal of infectious diseases, 1991-11, Vol.164 (5), p.973-975</ispartof><rights>Copyright 1991 The University of Chicago</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30112014$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30112014$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5065109$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1682395$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sha, Beverly E.</creatorcontrib><creatorcontrib>Harris, Alan A.</creatorcontrib><creatorcontrib>Benson, Constance A.</creatorcontrib><creatorcontrib>Atkinson, William L.</creatorcontrib><creatorcontrib>Urbanski, Pamela A.</creatorcontrib><creatorcontrib>Stewart, John A.</creatorcontrib><creatorcontrib>Williams, Walter W.</creatorcontrib><creatorcontrib>Murphy, Robert L.</creatorcontrib><creatorcontrib>Phair, John P.</creatorcontrib><creatorcontrib>Levin, Stuart A.</creatorcontrib><creatorcontrib>Kessler, Harold A.</creatorcontrib><title>Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 ofimmunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient &lt;1%) lacked levels of antibody considered protective, Neither the presence nor the level of antibody were predictable from patient age, history of measles or immunization, CD4+ lymphocyte count, percentage of CD4+ cells, or CD4:CD8 ratio. Nearly all subjects had antibody to measles, regardless of immunization or measles history. Whether these antibodies are truly protective is unknown.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>Biological and medical sciences</subject><subject>CD4-Positive T-Lymphocytes</subject><subject>Chicago - epidemiology</subject><subject>Children</subject><subject>Concise Communications</subject><subject>Disease Susceptibility</subject><subject>Female</subject><subject>HIV Infections - complications</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Leukocyte Count</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Measles</subject><subject>Measles - complications</subject><subject>Measles - epidemiology</subject><subject>Measles - immunology</subject><subject>Measles Vaccine - immunology</subject><subject>Measles virus - immunology</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Notifiable diseases</subject><subject>Patient medical history</subject><subject>Percentages</subject><subject>Prevalence</subject><subject>Surveys and Questionnaires</subject><subject>Vaccination</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNpFkM1vEzEQxS0EKmnhzgVpD4jbpmN77V0fQwVNRBA9AEKVkOX4Q3LZ9aa2FzX_PY42hNNY-r33ZvwQeoNhiUHQax-c8eka82bJlqKlz9ACM9rWnGP6HC0ACKlxJ8RLdJnSAwA0lLcX6ALzjlDBFujXXbR_VG-DttXoqi9Wpd6mahWy343Gl6cP1Sodhn0eB5W9rtbToEK1GYYpjMY6r30xH6ofPk6p3gRndbamWpmpz-kVeuFUn-zr07xC3z99_Hazrrdfbzc3q22taUdzzQkRWmnDOgyEOcwdJzvijreyxsEODOCuo6C50KT80gihlHCYckUwVZheofdz7j6Oj5NNWQ4-adv3KthxSrIlDcNcHIUwC3UcU4rWyX30g4oHiUEeG5Vzo7I0Kpksu4rl7Sl72g3W_DfMFRb-7sRV0qp3UQVdAv7JGHB2DD7HPKQ8xjOmgDEB3BRez9ynbJ_OXMXfkre0ZXL9817e37YfPtMtyDv6F0sbmEM</recordid><startdate>19911101</startdate><enddate>19911101</enddate><creator>Sha, Beverly E.</creator><creator>Harris, Alan A.</creator><creator>Benson, Constance A.</creator><creator>Atkinson, William L.</creator><creator>Urbanski, Pamela A.</creator><creator>Stewart, John A.</creator><creator>Williams, Walter W.</creator><creator>Murphy, Robert L.</creator><creator>Phair, John P.</creator><creator>Levin, Stuart A.</creator><creator>Kessler, Harold A.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19911101</creationdate><title>Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults</title><author>Sha, Beverly E. ; Harris, Alan A. ; Benson, Constance A. ; Atkinson, William L. ; Urbanski, Pamela A. ; Stewart, John A. ; Williams, Walter W. ; Murphy, Robert L. ; Phair, John P. ; Levin, Stuart A. ; Kessler, Harold A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>Biological and medical sciences</topic><topic>CD4-Positive T-Lymphocytes</topic><topic>Chicago - epidemiology</topic><topic>Children</topic><topic>Concise Communications</topic><topic>Disease Susceptibility</topic><topic>Female</topic><topic>HIV Infections - complications</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Leukocyte Count</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Measles</topic><topic>Measles - complications</topic><topic>Measles - epidemiology</topic><topic>Measles - immunology</topic><topic>Measles Vaccine - immunology</topic><topic>Measles virus - immunology</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Notifiable diseases</topic><topic>Patient medical history</topic><topic>Percentages</topic><topic>Prevalence</topic><topic>Surveys and Questionnaires</topic><topic>Vaccination</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sha, Beverly E.</creatorcontrib><creatorcontrib>Harris, Alan A.</creatorcontrib><creatorcontrib>Benson, Constance A.</creatorcontrib><creatorcontrib>Atkinson, William L.</creatorcontrib><creatorcontrib>Urbanski, Pamela A.</creatorcontrib><creatorcontrib>Stewart, John A.</creatorcontrib><creatorcontrib>Williams, Walter W.</creatorcontrib><creatorcontrib>Murphy, Robert L.</creatorcontrib><creatorcontrib>Phair, John P.</creatorcontrib><creatorcontrib>Levin, Stuart A.</creatorcontrib><creatorcontrib>Kessler, Harold A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sha, Beverly E.</au><au>Harris, Alan A.</au><au>Benson, Constance A.</au><au>Atkinson, William L.</au><au>Urbanski, Pamela A.</au><au>Stewart, John A.</au><au>Williams, Walter W.</au><au>Murphy, Robert L.</au><au>Phair, John P.</au><au>Levin, Stuart A.</au><au>Kessler, Harold A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1991-11-01</date><risdate>1991</risdate><volume>164</volume><issue>5</issue><spage>973</spage><epage>975</epage><pages>973-975</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 ofimmunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient &lt;1%) lacked levels of antibody considered protective, Neither the presence nor the level of antibody were predictable from patient age, history of measles or immunization, CD4+ lymphocyte count, percentage of CD4+ cells, or CD4:CD8 ratio. Nearly all subjects had antibody to measles, regardless of immunization or measles history. Whether these antibodies are truly protective is unknown.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>1682395</pmid><doi>10.1093/infdis/164.5.973</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1991-11, Vol.164 (5), p.973-975
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_72451691
source JSTOR Archival Journals and Primary Sources Collection【Remote access available】; Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Adult
AIDS/HIV
Antibodies
Antibodies, Viral - blood
Biological and medical sciences
CD4-Positive T-Lymphocytes
Chicago - epidemiology
Children
Concise Communications
Disease Susceptibility
Female
HIV Infections - complications
Humans
Immunization
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Leukocyte Count
Lymphocytes
Male
Measles
Measles - complications
Measles - epidemiology
Measles - immunology
Measles Vaccine - immunology
Measles virus - immunology
Medical sciences
Middle Aged
Notifiable diseases
Patient medical history
Percentages
Prevalence
Surveys and Questionnaires
Vaccination
Viruses
title Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A30%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Measles%20Antibodies%20in%20Asymptomatic%20Human%20Immunodeficiency%20Virus-Infected%20Adults&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Sha,%20Beverly%20E.&rft.date=1991-11-01&rft.volume=164&rft.issue=5&rft.spage=973&rft.epage=975&rft.pages=973-975&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/164.5.973&rft_dat=%3Cjstor_proqu%3E30112014%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72451691&rft_id=info:pmid/1682395&rft_jstor_id=30112014&rfr_iscdi=true